Rebaseline no evidence of disease activity (NEDA-3) as a predictor of long-term disease course in a Norwegian multiple sclerosis population.

Saved in:
Bibliographic Details
Title: Rebaseline no evidence of disease activity (NEDA-3) as a predictor of long-term disease course in a Norwegian multiple sclerosis population.
Authors: Simonsen CS; Department of Neurology, Vestre Viken Hospital Trust, Drammen, Norway., Flemmen HØ; Department of Neurology, Hospital Telemark HF, Skien, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Broch L; Department of Neurology, Vestre Viken Hospital Trust, Drammen, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Neurology, Oslo University Hospital, Oslo, Norway., Brekke K; Department of Neurology, Vestre Viken Hospital Trust, Drammen, Norway.; Department of Neurology, Hospital Vestfold, Tønsberg, Norway., Brunborg C; Oslo Centre for Biostatistics and Epidemiology, Research Support Services, Oslo University Hospital, Oslo, Norway., Berg-Hansen P; Department of Neurology, Oslo University Hospital, Oslo, Norway., Celius EG; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Neurology, Oslo University Hospital, Oslo, Norway.
Source: Frontiers in neurology [Front Neurol] 2022 Nov 14; Vol. 13, pp. 1034056. Date of Electronic Publication: 2022 Nov 14 (Print Publication: 2022).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation Country of Publication: Switzerland NLM ID: 101546899 Publication Model: eCollection Cited Medium: Print ISSN: 1664-2295 (Print) Linking ISSN: 16642295 NLM ISO Abbreviation: Front Neurol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1664-2295
DOI:10.3389/fneur.2022.1034056